1.75 / 0.59%
Latest price in CHFToday's changeShares traded1 year changeBeta
Data delayed at least 30 minutes, as of Apr 01 2015 10:09 BST.


As of last trade BB Biotech AG (BION:SWX) traded at 297.00, 17.10 % below its 52-week high of 358.25, set on Mar 16, 2015.

52-week range
Apr 14 2014
Mar 16 2015
Markit short selling activity
Day high299.25
Day low294.00
Previous close298.75
Average volume116.64k
Shares outstanding11.85m
Free float10.60m
P/E (TTM)2.30
Market cap3.54bn CHF
EPS (TTM)130.03 CHF
Annual div (IAD)11.60 CHF
Annual div yield (IAD)3.82%
Div ex-dateMar 20 2015
Div pay-dateMar 24 2015
Data delayed at least 30 minutes, as of Apr 01 2015 10:09 BST.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
BB Biotech AG+0.34 %+4.21 %+62.92 %+85.51 %+324.29 %
ALL SHARE CH X INDEX-0.31 %+1.69 %+4.86 %+8.56 %+31.05 %
Data delayed at least 30 minutes, as of Apr 01 2015 10:09 BST.
© Thomson Reuters Click for restrictions.

All markets data located on is subject to the FT Terms & Conditions.

All content on is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.